Relation of epicardial fat thickness to the severity of heart failure in patients with nonischemic dilated cardiomyopathy

Echocardiography

Volumn 32, Issue 5, 2015, Pages 740-748

  Tabakci, Mehmet Mustafa ^a   Durmuş, Halil Ibrahim ^b   Avci, Anil ^a   Toprak, Cuneyt ^a   Demir, Serdar ^a   Arslantaş, Uʇur ^a   Cerşit, Sinan ^a   Fidan, Serdar ^a   Kulahçioʇlu, Şeyhmus ^c   Batgerel, Ulaankhuu ^a   Kargin, Ramazan ^a  

^a Kartal Kosuyolu Training and Research Hospital   (Turkey)

^b Kutahya Tavsanli State Hospital   (Turkey)

^c Sultanbeyli State Hospital   (Turkey)

Author keywords

dilated cardiomyopathy; echocardiography; ejection fraction; heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EPICARDIAL FAT THICKNESS; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; LEFT ATRIUM VOLUME INDEX; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; NONISCHEMIC DILATED CARDIOMYOPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ADIPOSE TISSUE; BLOOD; COMPLICATION; ECHOGRAPHY; HEART VENTRICLE; MIDDLE AGED; PERICARDIUM; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ADIPOSE TISSUE; BODY MASS INDEX; CARDIOMYOPATHY, DILATED; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PERICARDIUM; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84928320773     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/echo.12796     Document Type: Article

References (35)

1. Schocken DD, Benjamin EJ, Fonarow GC, et al. Prevention of heart failure: A scientific statement from the American Heart Association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; Quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology inter- disciplinary working group. Circulation 2008; 117: 2544-2565.
2. Alla F, Zannad F, Filippatos G,: Epidemiology of acute heart failure syndromes. Heart Fail Rev 2007; 12: 91-95.
3. Wu AH,: Management of patients with non-ischemic cardiomyopathy. Heart 2007; 93: 403-408.
4. Okutucu S, Oto A,: Risk stratification in non-ischemic dilated cardiomyopathy: Current perspectives. Cardiol J 2010; 17: 219-229.
5. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-2466.
6. Baker AR, Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 13: 1.
7. Chaldakov GN, Fiore M, Stankulov IS, et al. Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: A role for NGF and BDNF in cardiovascular disease? Prog Brain Res 2004; 146: 279-289.
8. Kremen J, Dolinkova M, Krajickova J, et al. Increased subcutaneous and epicardial adipose tissue production of pro-inflammatory cytokines in cardiac surgery patients: Possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006; 91: 4620-4627.
9. Cheng KH, Chu CS, Lee KT, et al. Adipocytokines and pro-inflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008; 32: 268-274.
10. Fain JN, Sacks HS, Buehrer B, et al. Identification of omentin mRNA in human epicardial adipose tissue: Comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obes (Lond) 2008; 32: 810-815.
11. Shirani J, Berezowski K, Roberts WC,: Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am J Cardiol 1995; 76: 414-418.
12. Ding J, Kritchevsky SB, Harris TB, et al. The association of pericardial fat with calcified coronary plaque. Obesity (Silver Spring) 2008; 16: 1914-1919.
13. Wheeler GL, Shi R, Beck SR, et al. Pericardial and visceral adipose tissues measured volumetrically with computed tomography are highly associated in type 2 diabetic families. Invest Radiol 2005; 40: 97-101.
14. Taguchi R, Takasu J, Itani Y, et al. Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 2001; 157: 203-209.
15. Gorter PM, de Vos AM, van der Graaf Y, et al. Relation of epicardial and peri- coronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol 2008; 102: 380-385.
16. Batal O, Schoenhagen P, Shao M, et al. Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 230-236.
17. Wang T, Liu Q, Liu C, et al. Correlation of echocardiographic epicardial fat thickness with severity of coronary artery disease in patients with acute myocardial infarction. Echocardiography 2014; 31: 1177-1181.
18. Bland JM, Altman DG,: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
19. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. J Am Soc Echocardiography 2005; 18: 1440-1463.
20. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
21. Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: A new method for visceral adipose tissue prediction. Obes Res 2003; 11: 304-310.
22. Iacobellis G, Willens HJ,: Echocardiographic epicardial fat: A review of research and clinical applications. J Am Soc Echocardiogr 2009; 22: 1311-1319.
23. Iacobellis G, Corradi D, Sharma AM,: Epicardial adipose tissue: Anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2: 536-543.
24. Schejbal V,: Epicardial fatty tissue of the right ventricle morphology, morphometry and functional significance. Pneumologie 1989; 43: 490-499.
25. Khawaja T, Greer C, Chokshi A, et al. Epicardial fat volume in patients with left ventricular systolic dysfunction. Am J Cardiol 2011; 108: 397-401.
26. Doesch C, Haghi D, Fluchter S, et al. Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson 2010; 12: 40.
27. Mookadam F, Goel R, Alharthi MS, et al. Epicardial fat and its association with cardiovascular risk: A cross-sectional observational study. Heart Views 2010; 11: 103-108.
28. Karayannis G, Giamouzis G, Tziolas N, et al. Association between epicardial fat thickness and weight homeostasis hormones in patients with noncachectic heart failure. Angiology 2013; 64: 173-180.
29. Papotti M, Ghe C, Cassoni P, et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 2000; 85: 3803-3807.
30. Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004; 110: 3674-3679.
31. Iacobellis G, Pistilli D, Gucciardo M, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005; 29: 251-255.
32. Cheng VL, Kazanegra R, Garcia A, et al. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure. J Am Coll Cardiol 2001; 37: 386-391.
33. Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure. J Am Coll Cardiol 2004; 43: 635-641.
34. Verdiani V, Nozzoli C, Bacci F, et al. Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit. Eur J Heart Fail 2005; 7: 566-571.
35. Ahmed A,: A propensity matched study of New York Heart Association class and natural history end points in heart failure. Am J Cardiol 2007; 99: 549-553.